IC 307-2024: The Failed Hip Arthroscopy: How to Successfully Manage (and Not Replace) It
Image For Activity Cover
Availability
On-Demand
Expires on Sep 30, 2027
Cost
Member: $20.00
Resident/Fellow Member: $20.00
Affiliate Member: $20.00
Non-Member: $30.00
Credit Offered
1.5 CME Credits
1.5 Category A CEU Credits
  • Course Information
  • ADDITIONAL INFORMATION

This course includes the recording of a live Instructional Course from the 2024 AOSSM Annual Meeting which took place in Denver, CO.

IC 307: The Failed Hip Arthroscopy: How to Successfully Manage (and Not Replace) It

Course Description:

This ICL will discuss the approach to the failed hip arthroscopy - (1) the failed FAI surgery evaluation and treatment, (2) capsular defects - arthroscopic repair and arthroscopic reconstruction (3) management and approach to the lack of reparable labral tissue including segmental and circumferential labral reconstruction and (4) when the problem is not manageable with the scope - when to send for PAO, open surgical dislocation, and femoral osteotomy.

Learning Objectives: 

At the conclusion of the course, participants will:

  • Be able to list the more common causes of failed hip arthroscopy and know how to evaluate for each of these potential causes.
  • Know when to perform a labral reconstruction and understand the different grafts and techniques.
  • Know how to reconstruct the capsule in cases of capsular deficiency.
  • Know when a PAO or open surgical dislocation should be considered in the patient who has failed a hip arthroscopy.
  • Know when a femoral derotational osteotomy is indicated for the patient who has failed hip arthroscopy.
Featured Topics: 
  • Introduction
  • Approach to Failed FAI Surgery: Evaluation of the failed FAI surgery, surgical approaches, and management of the various causes of failed FAI surgery – Marc Safran
  • Labral Deficiency: Will talk about the management of labral defects including segmental and circumferential labral reconstruction, graft types, including autograft, allograft, and local tissues, as well as indications for labral augmentation - Shane Nho
  • Capsular Defects: will talk about capsular repair and the technique and outcomes of capsular reconstruction, including graft types and technical tips - Marc Philippon
  • When You Cannot Fix It with the Scope: Will talk about the indications and contraindications of PAO, Surgical Dislocation and Femoral Derotational Osteotomy in the management of bony deficiency and version abnormalities - Andrea Spiker
  • Q&A


Faculty:

  • Marc R. Safran, MD
  • Shane J. Nho, MD, MS
  • Marc J. Philippon, Jr, MD
  • Andrea M. Spiker, MD
Accreditation

ACCREDITATION STATEMENT The American Orthopaedic Society for Sports Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.



Credit Information

AMA CREDIT DESIGNATION STATEMENT The American Orthopaedic Society for Sports Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CLAIMING CREDIT In order to obtain AMA PRA Category 1 Credits™ participants must complete the activity and evaluation. Please note that this is an online-only activity. Participants must complete the activity and evaluation online. No hard copy submissions will be accepted.

ABOS MOC CREDIT STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.

The American Orthopaedic Society for Sports Medicine (AOSSM) (BOC AP#: P460) is approved by the Board of Certification, Inc. to provide continuing education for Athletic Trainers. This live activity is eligible for a maximum of 1.5 Category A hours/CEUs. ATs should claim only those hours actually spent in the educational program.

Disclosures
Name Disclosure Details
Nho, Shane (MD, MS) Royalties, Financial or Material Support from Publishers relationship with Sports Med Innovate; Research Support relationship with Johnson & Johnson; Royalties relationship with Stryker Corporation; Royalties, Financial or Material Support from Publishers relationship with Springer; Stock or Stock Options relationship with Patient IQ; Paid Consultant relationship with Ossur; Royalties relationship with Ossur; Research Support relationship with Stryker; Paid Consultant relationship with Stryker Corporation
Philippon, Marc (MD) Royalties, Financial or Material Support from Publishers relationship with Elsevier; Royalties relationship with Elsevier; Royalties relationship with Arthrex, Inc; Royalties relationship with Arthrosurface; Royalties relationship with Smith and Nephew; Paid Consultant relationship with Smith and Nephew; Paid Consultant relationship with Arthrex; Royalties relationship with ConMed Linvatec; Stock or Stock Options relationship with Vail valley surgery center; Stock or Stock Options relationship with stryker; Royalties relationship with Bledsoe; Research Support relationship with Vail Valley medical center; Stock or Stock Options relationship with Trimble; Stock or Stock Options relationship with Steadman Philippon Surgery Center; Royalties relationship with DJO; Stock or Stock Options relationship with Pfizer; Stock or Stock Options relationship with AbbVie; Stock or Stock Options relationship with Johnson & Johnson; Stock or Stock Options relationship with DocBuddy; Research Support relationship with Smith+Nephew, Inc.; Research Support relationship with Ossur; Research Support relationship with Arthrex; Research Support relationship with Siemens; Royalties, Financial or Material Support from Publishers relationship with SLACK Inc.; Stock or Stock Options relationship with Bristol Myers Squibb; Stock or Stock Options relationship with 3M; Stock or Stock Options relationship with Vail MSO Holdings LLC; Royalties relationship with SLACK Inc.; Stock or Stock Options relationship with Grocery Outlet; Paid Consultant relationship with MIS; Paid Consultant relationship with Olatec; Stock or Stock Options relationship with Arthrosurface; Stock or Stock Options relationship with MIS; Stock or Stock Options relationship with Stryker; Stock or Stock Options relationship with Olatec; Stock or Stock Options relationship with EffRx; Stock or Stock Options relationship with Dillon Surgery Center; Stock or Stock Options relationship with MJP Innovations, LLC
Safran, Marc (MD) Royalties relationship with Medacta; Royalties relationship with DJO; Royalties relationship with Top Shelf; Royalties relationship with Smith and Nephew; Unpaid Consultant relationship with Subchondral Solutions; Royalties relationship with Vive Health; Royalties, Financial or Material Support from Publishers relationship with Elsevier; Royalties, Financial or Material Support from Publishers relationship with Lippincott; Speaker's Bureau/Presenter relationship with Smith and Nephew; Unpaid Consultant relationship with Marrow Access Technologies; Research Support relationship with Smith and Nephew; Other Financial or Material Support relationship with Smith and Nephew; Unpaid Consultant relationship with Organogenesis; Paid Consultant relationship with Medacta
Spiker, Andrea (MD) Paid Consultant relationship with Stryker
Marisol Claich (Staff Planner) Nothing to disclose
Jan Foecke (Staff Planner) Nothing to disclose

 


In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.

Release Date: 10/01/2024
Expiration Date: 9/30/2027
Android App Download IOS App Download Powered By